Mostrar el registro sencillo del ítem

Immunomodulatory and immunosuppressive therapies in cardiovascular disease and type 2 diabetes mellitus: a bedside-to-bench approach

dc.contributor.authorMikkelsen, R. R.
dc.contributor.authorHundahl, M. P.
dc.contributor.authorTorp, C. K.
dc.contributor.authorRodríguez Carrio, Javier 
dc.contributor.authorKjolby, M.
dc.contributor.authorBruun, J. M.
dc.contributor.authorKragstrup, T. W.
dc.date.accessioned2022-11-08T12:44:08Z
dc.date.available2022-11-08T12:44:08Z
dc.date.issued2022
dc.identifier.citationEuropean Journal of Pharmacology, 925 (2022); doi:10.1016/j.ejphar.2022.174998
dc.identifier.issn0014-2999
dc.identifier.urihttp://hdl.handle.net/10651/65535
dc.description.sponsorshipTWK was supported by a grant from Independent Research Fund Denmark (9039-00015 B). MK was supported by The Lundbeck Foundation . JRC is supported by Fondo de Investigación Sanitaria (from Instituto de Salud Carlos III, Spain; grant reference PI21/00054).
dc.language.isoeng
dc.relation.ispartofEuropean Journal of Pharmacology
dc.rights© 2022 Los autores
dc.rightsCC Reconocimiento 4.0 Internacional
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScopus
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85129936617&doi=10.1016%2fj.ejphar.2022.174998&partnerID=40&md5=442baa1006d2c7f66a167afe5b0a0f57
dc.titleImmunomodulatory and immunosuppressive therapies in cardiovascular disease and type 2 diabetes mellitus: a bedside-to-bench approach
dc.typejournal article
dc.identifier.doi10.1016/j.ejphar.2022.174998
dc.relation.projectIDISCIII/PI21/00054
dc.relation.publisherversionhttp://dx.doi.org/10.1016/j.ejphar.2022.174998
dc.rights.accessRightsopen access
dc.type.hasVersionVoR


Ficheros en el ítem

untranslated

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

© 2022 Los autores
Este ítem está sujeto a una licencia Creative Commons